对于多发性骨髓瘤和AL氨基粉症的BCL2抑制
Lorenzo Cani1,2, Vikas A Gupta1, Jonathan L Kaufman1
1Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
British journal of haematology
|March 16, 2025
概括
BCL2抑制剂对治疗多发性骨髓瘤 (MM) 和轻链 (AL) 氨基粉症有前途,特别是在具有t(11;14) 转位的患者中. 由于潜在的毒性,仔细选择患者和剂量至关重要.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性骨髓瘤 (MM) 和轻链性粉样性粉症 (AL) 仍然是无法治愈的血液恶性瘤.
- BCL2 抑制剂代表了一种针对血细胞疾病的新型治疗类.
研究的目的:
- 审查BCL2抑制剂在治疗MM和AL氨基粉症中的当前作用和疗效.
- 讨论venetoclax和其他BCL2向剂的潜力.
主要方法:
- 对MM和AL氨基粉症中BCL2抑制剂的临床前和临床研究的综述.
- 来自随机试验和现实研究的疗效数据的分析.
- 检查安全概况和毒性问题.
主要成果:
- 威尼托克拉克斯在MM和AL氨基粉症中表现出有希望的疗效,作为单疗法或组合治疗.
- 强有力的数据支持在患有t(11;14) 转位的患者中使用BCL2抑制剂.
- 目前正在进行的研究正在调查其他向BCL2的药物.
结论:
- BCL2 抑制剂是MM和AL氨基粉症治疗领域的重要补充.
- 优化患者选择和剂量对于管理毒性至关重要.
- 对新的BCL2向疗法进行进一步的研究是有必要的.
更多相关视频
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
13.1K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.7K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K